Internal Medicine · Houston, TX
NPI
1235355330
Since 2007
Specialty
Internal Medicine
Code 207R00000X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
1724 Richmond Ave
Houston, TX, 77098
Phone (713) 526-5955
Groups this clinician bills Medicare through
Medicare paid, 2024
$367K
5,037 services
Medicare patients, 2024
416
Average age 73
Drug cost, 2024
$527K
1,251 prescriptions
Company payments, 2025
$81.4
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jorge A Zuniga was code 99232 (hospital e&m - subsequent), 2,982 times for 279 patients. In total Jorge A Zuniga billed 5,037 services in 26 codes, and Medicare paid $367K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 2,982 | 279 | $58.74 | $175K |
| 99233 Hospital E&M - Subsequent | Facility | 1,282 | 257 | $87.89 | $113K |
| 99214 Office E&M - Established | Office | 312 | 82 | $91.60 | $29K |
| 99223 Hospital E&M - Initial | Facility | 271 | 225 | $130.19 | $35K |
| 99222 Hospital E&M - Initial | Facility | 103 | 85 | $95.19 | $9,804 |
| 99204 Office E&M - New | Office | 18 | 17 | $125.59 | $2,261 |
By year: 2022 $387K for 5,678 services; 2023 $330K for 4,288 services; 2024 $367K for 5,037 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jorge A Zuniga prescribed most often to Medicare patients was Daptomycin, with 218 prescriptions and refills. In total Jorge A Zuniga wrote 1,251 Medicare prescriptions that cost $527K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Daptomycin Generic | 218 | 218 | 42 | $185K |
| Meropenem Generic | 136 | 136 | 26 | $21K |
| Cefepime Hcl Generic | 123 | 123 | 30 | $24K |
| Ertapenem Ertapenem Sodium | 104 | 104 | 40 | $44K |
| Minocycline Hcl Generic | 68 | 145 | 27 | $5,637 |
| Ceftriaxone Ceftriaxone Sodium | 44 | 44 | 14 | $2,432 |
| Doxycycline Hyclate Generic | 35 | 78 | 17 | $1,318 |
| Vancomycin Hcl Generic | 29 | 29 | Under 11 | $7,280 |
| Micafungin Micafungin Sodium | 28 | 28 | Under 11 | $19K |
| Levofloxacin Generic | 24 | 32 | 15 | $397 |
| Fluconazole Generic | 21 | 31 | 11 | $287 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 19 | 29 | 13 | $520 |
| Amoxicillin Generic | 17 | 39 | Under 11 | $522 |
| Mounjaro Tirzepatide | 16 | 23 | Under 11 | $24K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 15 | 24 | Under 11 | $150 |
Brand drugs: - claims; generic drugs: 1,153 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jorge A Zuniga $81.4 ($81.4 in general payments such as food, travel and fees) from 1 company. The largest payer was Melinta Therapeutics, LLC with $81.4.
| Company | Payments | Amount |
|---|---|---|
| Melinta Therapeutics, LLC | 2 | $81.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.